Concepedia

Generic Drug Entry

Generic Drug Entry is a pharmaceutical market event defined by the first introduction of a chemically equivalent, non-branded version of a previously patented drug into the market following the expiration or invalidation of intellectual property protections, thereby enabling price competition.

147

Publications

7.4K

Citations

311

Authors

180

Institutions

Publications per year

2017–2026

43

Parents

Publications

147

Generic Entry and the Pricing of Pharmaceuticals

Richard G. Frank, David S. Salkever · Journal of Economics & Management Strategy · 1997 · 384 citations · Full text

, , +8

Generic Drug Industry Dynamics

David Reiffen, Michael R. Ward · The Review of Economics and Statistics · 2005 · 297 citations

, , +15

Generic Entry and the Pricing of Pharmaceuticals

Richard G. Frank, David S. Salkever · Journal of Economics & Management Strategy · 1997 · 268 citations

, , +8

Evergreening, patent challenges, and effective market life in pharmaceuticals

C. Scott Hemphill, Bhaven N. Sampat · Journal of Health Economics · 2012 · 244 citations

, , +13

Barriers to entry, brand advertising, and generic entry in the US pharmaceutical industry

Fiona M. Scott Morton · International Journal of Industrial Organization · 2000 · 241 citations

, , +13

1–5 of 147

Authors

311

  1. AS
    Aaron S. Kesselheim

    Brigham and Women's Hospital, United States

    8 publications · 201 citations

    8

    h-index

  2. ER
    Ernst R. Berndt

    Massachusetts Institute of Technology, United States

    6 publications · 273 citations

    7

    h-index

  3. HG
    Henry G. Grabowski

    Duke University, United States

    6 publications · 500 citations

    6

    h-index

  4. RG
    Richard G. Frank

    Harvard University, United States

    6 publications · 950 citations

    6

    h-index

  5. RF
    Reed F. Beall

    University of Calgary, Canada

    5 publications · 119 citations

    5

    h-index

1–5 of 311

Institutions

180

  1. Harvard University

    Cambridge, United States

    12 h-index

    38 publications

    1.2K citations

  2. National Bureau of Economic Research

    Cambridge, United States

    10 h-index

    19 publications

    718 citations

  3. Brigham and Women's Hospital

    Boston, United States

    9 h-index

    25 publications

    614 citations

  4. Duke University

    Durham, United States

    8 h-index

    9 publications

    579 citations

  5. Analysis Group (United States)

    Boston, United States

    6 h-index

    13 publications

    904 citations

  6. London School of Economics and Political Science

    London, United Kingdom

    6 h-index

    12 publications

    971 citations

  7. Cornell University

    Ithaca, United States

    5 h-index

    22 publications

    2.4K citations

  8. United States Food and Drug Administration

    Silver Spring, United States

    5 h-index

    9 publications

    162 citations

1–8 of 180

Venues

  1. SSRN Electronic Journal

    Repository · 18 publications · 387 citations

    12

    h-index

  2. National Bureau of Economic Research

    Repository · 6 publications · 337 citations

    6

    h-index

  3. Journal of Health Economics

    5 publications · 459 citations

    5

    h-index

  4. PubMed

    Repository · 4 publications · 133 citations

    4

    h-index

  5. Health Affairs

    4 publications · 192 citations

    4

    h-index

1–5